Clinical Trial Results

Showing: All studies [change]
Condition: Obesity Location: San Antonio, Texas 25 trials found
New Search
Filter
Trial Phase
Study Type
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
NAINTERVENTIONAL Baltimore, Maryland +1 more
RECRUITING
Prevention of Progression of Prediabetes, Obesity and CV Risk
PHASE1INTERVENTIONAL San Antonio, Texas
RECRUITING
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
PHASE2INTERVENTIONAL San Dimas, California +4 more
RECRUITING
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
PHASE2INTERVENTIONAL San Antonio, Texas
RECRUITING
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
PHASE4INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
PHASE3INTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
PHASE3INTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
PHASE3INTERVENTIONAL Northridge, California +4 more
RECRUITING
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
PHASE3INTERVENTIONAL Escondido, California +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Glendale, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
PHASE3INTERVENTIONAL Guntersville, Alabama +4 more
RECRUITING
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
PHASE1INTERVENTIONAL Miami, Florida +2 more
RECRUITING
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type